 |
|
|
|
|
|
|
|
 |
Results for 'Molecular Diagnostics: Major World Markets' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Molecular Diagnostics Markets
|
September 2008 |
£2290 |
50 % |
World Market for In Vitro Diagnostics 2005; The
|
January 2005 |
£1299 |
36 % |
Cell-Based Diagnostics: Technology, Applications, and Markets
2nd Edition
|
November 2007 |
£2690 |
35.5 % |
Molecular Diagnostics
Major World Markets
|
February 2007 |
£2690 |
35 % |
Diabetes, Metabolic Syndrome and Cardiovascular Disease Markets
Reshaping Tomorrow's Diabetes Market
|
October 2005 |
£1345 |
33 % |
Cell Culture
The World Market for Media, Sera, and Reagents
|
January 2007 |
£2625 |
29.75 % |
Biomarkers: A Market Briefing
A Market Briefing
|
January 2007 |
£1345 |
29.75 % |
Pancreatic Cancer
Gold Standard Gemcitabine Waiting to be Challenged
|
December 2004 |
£8000 |
29.5 % |
Companion Diagnostics Markets
(A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine)
|
June 2008 |
£2015 |
29.05 % |
Molecular Biomarkers for Clinical Diagnostics and Drug Discovery and Development
|
August 2001 |
£1110 |
28.7 % |
Molecular Diagnostics 2007
Technologies, Companies, Products, Applications and Worldwide Outlook
|
May 2007 |
£1700 |
28.7 % |
Commercializing Molecular Diagnostics:
Products, Services, Companies and Global Market
|
July 2008 |
£1745 |
28 % |
Innovations in Cancer
Novel Therapeutics, New Diagnostics and Future R&D Strategies
|
February 2007 |
£1495 |
26 % |
Biomarkers & Related Tests for Molecular Diagnostics & Pharma/ Biotech R&D
Companies, Products & Worldwide Market, 2004-2009
|
July 2005 |
£1275 |
25.9 % |
Medical Imaging Markets, Volume IV
Contrast Agents
|
February 2007 |
£2015 |
25 % |
The Worldwide Market for In Vitro Diagnostic Tests
6th Edition
|
May 2008 |
£3365 |
25 % |
Executive Summary of the BioChips & BioMEMS (Biomedical Microelectromechanical Systems) Markets
2006-2011 Analysis & Forecasts
|
May 2006 |
£735 |
23 % |
BioChips & BioMEMS (Bio Microelectromechanical Systems) World Markets, Applications & Opportunities
2006-2011 Analysis & Forecasts
|
May 2006 |
£1210 |
23 % |
Complete Guide to the Diagnostic Market 2007-2012
|
January 2007 |
£1600 |
22.4 % |
Convergence of Biomarkers and Diagnostics, The
Therapy Area Analyses, Key Products and Future Trends
|
April 2008 |
£1995 |
21.5 % |
World Enzymes
Study # 2229
|
September 2007 |
£1805 |
18.2 % |
DNA Sequencing and PCR Markets
|
July 2008 |
£2290 |
17.5 % |
Biomarkers: The Future of Next-Generation Drug R&D
|
September 2008 |
£1745 |
17.15 % |
Lateral Flow Technology and the Future of Point of Care Diagnostics
|
February 2007 |
£2015 |
16.1 % |
Genomics World Markets
|
May 2008 |
£2290 |
16.1 % |
Biomarkers
The Expanding Global Market
|
November 2007 |
£1625 |
16.1 % |
Companion Diagnostics in Personalized Medicine and Cancer Therapy
|
April 2008 |
£2290 |
14.7 % |
Blood
The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
|
September 2006 |
£2625 |
14.35 % |
In-Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
14 % |
In Vitro Diagnostics Market Report & Analysis 2008-2023
|
June 2008 |
£1499 |
14 % |
Labeling and Linkage Agents for Immunoassays and Gene Probes
|
April 2006 |
£3265 |
12.95 % |
Biomarkers
|
January 2008 |
£2230 |
11.9 % |
Key Diagnostic Testing Markets
|
December 2004 |
£1345 |
11.55 % |
Protein Therapeutics Market; The
The Science and Business of a Growing Sector
|
June 2006 |
£2625 |
11.55 % |
Animal Biotechnology
Technologies, Markets and Companies
|
September 2008 |
£900 |
11.2 % |
Medical Imaging Markets
|
December 2007 |
£2290 |
11.2 % |
DNA Sequencing
|
February 2008 |
£3030 |
11.2 % |
Nanotechnology
Revolutionizing R&D to Develop Smarter Therapeutics and Diagnostics
|
January 2008 |
£1995 |
10.5 % |
Pharmaceutical Contract Manufacturing and Research
|
May 2005 |
£3060 |
10.5 % |
Taq Wars; The
Competitive Intelligence on How to Survive
|
November 2005 |
£3030 |
10.5 % |
Nanomedicine 2006-2011
|
June 2006 |
£1499 |
10.15 % |
Nanotechnology and MEMS 2003
The Race to Commercialize the Ultra-Small
|
August 2003 |
£1005 |
9.8 % |
Live-Licensing & In-life Testing
R&D Processes and Regulation for New Drugs, 2008-2020
|
January 2008 |
£1499 |
9.45 % |
Alzheimer disease
new drugs, markets and companies
|
September 2008 |
£1885 |
7.35 % |
Japan Healthcare IT Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£2020 |
7 % |
RNA Interference Markets
|
September 2008 |
£1345 |
5.95 % |
|
|
|
|
